HRSA proposed rule would establish dispute resolution process for 340B program
The Health Resources and Services Administration today released a proposed rule that would implement an Affordable Care Act provision requiring a binding administrative dispute resolution process for 340B Drug Pricing Program participants who claim they have been overcharged for drugs purchased through the program. Under the proposed process, which also would be available to drug manufacturers, a decision-making body within the Department of Health and Human Services would review and resolve the claims. The proposed rule will be published in the Aug. 12 Federal Register with comments accepted through Oct. 11. AHA staff are reviewing the rule, and member hospitals that are 340B participants will receive more information.
Related News Articles
Headline
The Fund for Access to Inpatient Rehabilitation late yesterday announced that the government will settle backlogged Medicare inpatient rehabilitation facility…
Headline
The Medicare Payment Advisory Commission Friday issued its June report to Congress, which includes several recommendations approved by the panel during its…
Headline
Nine in 10 voters say access to health care in rural communities is important, and three in five would be more likely to vote for a candidate who prioritized…
Headline
The House Ways and Means Committee today held a hearing on “Pathways to Universal Health Coverage,” which debated various options to expand access to health…
Headline
The Centers for Medicare…
Headline
The U.S. Supreme Court today affirmed a D.C. Circuit Court decision that the Department of Health and Human Services violated the Medicare Act when it changed…